ITGB2 and Autoimmunity: Since activation of innate immunity is a hallmark of neuroimmune and neurodegenerative diseases, inhibiting the interaction of fibrinogen with CD11b/CD18 could be beneficial not only for suppressing autoimmunity, but also halting neurodegeneration.